Viewing StudyNCT00453167



Ignite Creation Date: 2024-05-05 @ 5:27 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00453167
Status: COMPLETED
Last Update Posted: 2010-07-12
First Post: 2007-03-27

Brief Title: Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung Cancer
Sponsor: National Cancer Center Korea
Organization: National Cancer Center Korea

Conditions & Keywords Data

Conditions:
Name
Lung Cancer
Keywords:
Name View
second-line therapy View
Small cell lung cancer View